Medical Article – Page 37

Articles

Cost per responder analysis of iptacopan versus eculizumab and ravulizumab in treatment of paroxysmal nocturnal hemoglobinuria

4 weeks ago03 mins

That is the tile of my recent paper in the Journal of Medical Economics with co-authors Kyi-Sin Than, Sanjana Muthukrishnan, Jincy Paulose, Ver Bilano and Nicholas Kuypers. The abstract is below: ObjectiveParoxysmal nocturnal hemoglobinuria (PNH) is a rare and debilitating hematological disease with significant economic burden. Despite the availability of multiple therapies, there is a…

Galapagos Says ‘No’ to SpinCo and Instead Will Seek Deals for All Assets

9 months ago01 mins

Galapagos has dropped plans for a business separation that would have enabled the legacy company to focus exclusively on developing new cancer cell therapies. Instead, Galapagos said it will pursue strategic alternatives for its assets. The post Galapagos Says ‘No’ to SpinCo and Instead Will Seek Deals for All Assets appeared first on MedCity News.

APIs in Healthcare – Magic in the Air

6 months ago01 mins

Picture each patient with a computational model of their health where each treatable parameter (like weight, blood pressure, heart rate, exercise, inflammation, and blood chemistry) serves both as a marker for diagnosis and as an opportunity for treatment. The post APIs in Healthcare – Magic in the Air appeared first on MedCity News.

Bad Provider Data Is Delaying Care and Driving Up Costs, CAQH CEO Warns

9 months ago01 mins

Inaccurate provider data is creating a hidden crisis in healthcare by delaying care and driving up costs for both patients and health plans, according to CAQH CEO Sarah Ahmad. Her organization is working to address the issue by improving how provider data is collected and verified on the front end. The post Bad Provider Data…

Journalists Dig Into Government Shutdown and Rural Doctor Drought

4 months ago03 mins

KFF Health News chief Washington correspondent Julie Rovner appeared on CNN’s “Quest Means Business” to discuss the Affordable Care Act subsidies at the core of the government shutdown on Oct. 2. Rovner also appeared on NPR’s “Morning Edition” to discuss the subsidies on Oct. 7. Click here to watch Rovner on “Quest Means Business.” Click…

States Are Forming “Health Alliances.” Can They Make a Difference for Public Health Policy?

4 months ago01 mins

States have begun to form “health alliances” as a counter to federal public health recommendations and policies under the Trump Administration. This Policy Watch describes the goals of these alliances, and discusses what effects they may have for U.S. public health policy.

Hospitals’ Lobbying Frustrates Montana Lawmakers Who Sought To Boost Oversight

10 months ago014 mins

HELENA, Mont. — As Republican legislative leaders in Montana girded for this year’s battle over whether to extend Medicaid expansion in the state, they took aim at one of the program’s biggest backers: hospitals. If Montana’s hospitals wanted to extend the government health insurance program that cost taxpayers about $1 billion in 2024, and benefit…

Más refugios atienden necesidades médicas de personas mayores sin techo

4 weeks ago013 mins

SANDY, Utah — Justo en las afueras de Salt Lake City se encuentra un viejo hotel de ladrillo de dos pisos. Hoy tiene una nueva función: refugio para personas mayores sin hogar. El refugio para Personas Médicamente Vulnerables —conocido como MVP, por sus siglas en inglés— está destinado a personas de 62 años en adelante,…

Articles

Will most favored nation reduce drug prices in the US…or raise prices in Europe?

6 months ago03 mins

The answer seems to be the latter. The Times (UK) reports. Eli Lilly, the US-based manufacturer of Mounjaro, said it was hiking the UK list price for the medication from September 1 to bring it in line with other nations…Eli Lilly is increasing the amount it charges pharmacies. The rate for a middle-sized 5mg dose…

Narcan, Drones, and Concerts: How Governments Spent Opioid Settlement Windfalls

3 months ago04 mins

Twenty-two million dollars to repay loans for people working in the addiction field. About $12,000 for gun silencers. Sixteen dollars for a children’s book about Spookley the Square Pumpkin. The purchases varied widely but they all came from the same source: opioid settlement money. The cash, which comes from companies accused of fueling the overdose…

KFF Health News’ ‘What the Health?’: Next on Kennedy’s List? Preventive Care and Vaccine Harm

Roche’s Metabolic Drug Strategy Extends to the Liver Disease MASH With $2.4B 89bio Acquisition

How Bright A Light Do We Shine This Memorial Day?

How Northwestern Medicine’s Value-Based Care Team Makes the Case for Investment

How Does the Federal Government Monitor Vaccine Safety?

Why Florida State Created an AI-Focused Nursing Degree

Cost per responder analysis of iptacopan versus eculizumab and ravulizumab in treatment of paroxysmal nocturnal hemoglobinuria

Galapagos Says ‘No’ to SpinCo and Instead Will Seek Deals for All Assets

APIs in Healthcare – Magic in the Air

Bad Provider Data Is Delaying Care and Driving Up Costs, CAQH CEO Warns

Journalists Dig Into Government Shutdown and Rural Doctor Drought

States Are Forming “Health Alliances.” Can They Make a Difference for Public Health Policy?

Hospitals’ Lobbying Frustrates Montana Lawmakers Who Sought To Boost Oversight

Más refugios atienden necesidades médicas de personas mayores sin techo

Will most favored nation reduce drug prices in the US…or raise prices in Europe?

Narcan, Drones, and Concerts: How Governments Spent Opioid Settlement Windfalls